These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17404285)

  • 21. Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells.
    Grueter B; Petter M; Egawa T; Laule-Kilian K; Aldrian CJ; Wuerch A; Ludwig Y; Fukuyama H; Wardemann H; Waldschuetz R; Möröy T; Taniuchi I; Steimle V; Littman DR; Ehlers M
    J Immunol; 2005 Aug; 175(3):1694-705. PubMed ID: 16034110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutive CD8 expression allows inefficient maturation of CD4+ helper T cells in class II major histocompatibility complex mutant mice.
    Robey E; Itano A; Fanslow WC; Fowlkes BJ
    J Exp Med; 1994 Jun; 179(6):1997-2004. PubMed ID: 7515104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional regulation of CD4 gene expression by T cell factor-1/beta-catenin pathway.
    Huang Z; Xie H; Ioannidis V; Held W; Clevers H; Sadim MS; Sun Z
    J Immunol; 2006 Apr; 176(8):4880-7. PubMed ID: 16585583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel mouse thymocyte antigen (F3Ag): down-regulation during the CD4+CD8+ double-positive stage indicates positive selection.
    Barthlott T; Potocnik AJ; Kohler H; Carsetti R; Pircher H; Fowlkes BJ; Eichmann K
    Int Immunol; 1996 Jan; 8(1):101-13. PubMed ID: 8671594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered thymocyte development resulting from expressing a deleting ligand on selecting thymic epithelium.
    Carlow DA; Teh SJ; Teh HS
    J Immunol; 1992 May; 148(10):2988-95. PubMed ID: 1578126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive selection of thymocytes induced by gene transfer: MHC class II-mediated selection of CD8 lineage cells.
    Rooke R; Waltzinger C; Benoist C; Mathis D
    Int Immunol; 1999 Oct; 11(10):1595-600. PubMed ID: 10508177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro differentiation and commitment of CD4+ CD8+ thymocytes to the CD4 lineage, without TCR engagement.
    Ohoka Y; Kuwata T; Tozawa Y; Zhao Y; Mukai M; Motegi Y; Suzuki R; Yokoyama M; Iwata M
    Int Immunol; 1996 Mar; 8(3):297-306. PubMed ID: 8671615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymic development in human CD4 transgenic mice. Positive selection occurs after commitment to the CD8 lineage.
    Paterson RK; Burkly LC; Kurahara DK; Dunlap A; Flavell RA; Finkel TH
    J Immunol; 1994 Oct; 153(8):3491-503. PubMed ID: 7930572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MEK activity regulates negative selection of immature CD4+CD8+ thymocytes.
    Bommhardt U; Scheuring Y; Bickel C; Zamoyska R; Hünig T
    J Immunol; 2000 Mar; 164(5):2326-37. PubMed ID: 10679067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coreceptor gene imprinting governs thymocyte lineage fate.
    Adoro S; McCaughtry T; Erman B; Alag A; Van Laethem F; Park JH; Tai X; Kimura M; Wang L; Grinberg A; Kubo M; Bosselut R; Love P; Singer A
    EMBO J; 2012 Jan; 31(2):366-77. PubMed ID: 22036949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymocyte-intrinsic genetic factors influence CD8 T cell lineage commitment and affect selection of a tumor-reactive TCR.
    Shanker A; Auphan-Anezin N; Chomez P; Giraudo L; Van den Eynde B; Schmitt-Verhulst AM
    J Immunol; 2004 Apr; 172(8):5069-77. PubMed ID: 15067090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of mature T cell populations in the thymus: CD4 or CD8 down-regulation occurs at different stages of thymocyte differentiation.
    Marodon G; Rocha B
    Eur J Immunol; 1994 Jan; 24(1):196-204. PubMed ID: 7912676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligand density determines the efficiency of negative selection in the thymus.
    Römermann D; Heath WR; Allison J; Bayer B; Sorge Y; Miller JF; Hoffmann MW
    Transplantation; 2001 Jul; 72(2):305-11. PubMed ID: 11477358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct differentiative stages of CD4+CD8+ thymocyte development defined by the lack of coreceptor binding in positive selection.
    Dutz JP; Ong CJ; Marth J; Teh HS
    J Immunol; 1995 Mar; 154(6):2588-99. PubMed ID: 7533178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replacement of pre-T cell receptor signaling functions by the CD4 coreceptor.
    Norment AM; Forbush KA; Nguyen N; Malissen M; Perlmutter RM
    J Exp Med; 1997 Jan; 185(1):121-30. PubMed ID: 8996248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strength of signaling by CD4 and CD8 coreceptor tails determines the number but not the lineage direction of positively selected thymocytes.
    Bosselut R; Feigenbaum L; Sharrow SO; Singer A
    Immunity; 2001 Apr; 14(4):483-94. PubMed ID: 11336693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The novel murine CD4+CD8+ thymocyte cell line exhibits lineage commitment into both CD4+ and CD8+ T cells by altering the intensity and the duration of anti-CD3 stimulation in vitro.
    Nishida T; Matsuki Y; Ono T; Oguma T; Tsujimoto K; Sato M; Tadakuma T
    J Immunol; 2004 Jun; 172(11):6634-41. PubMed ID: 15153478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymic selection in CD8 transgenic mice supports an instructive model for commitment to a CD4 or CD8 lineage.
    Robey EA; Fowlkes BJ; Gordon JW; Kioussis D; von Boehmer H; Ramsdell F; Axel R
    Cell; 1991 Jan; 64(1):99-107. PubMed ID: 1898873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly efficient selection of CD4 and CD8 lineage thymocytes supports an instructive model of lineage commitment.
    Itano A; Robey E
    Immunity; 2000 Apr; 12(4):383-9. PubMed ID: 10795736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of the Runx3 transcription factor increases the proportion of mature thymocytes of the CD8 single-positive lineage.
    Kohu K; Sato T; Ohno S; Hayashi K; Uchino R; Abe N; Nakazato M; Yoshida N; Kikuchi T; Iwakura Y; Inoue Y; Watanabe T; Habu S; Satake M
    J Immunol; 2005 Mar; 174(5):2627-36. PubMed ID: 15728469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.